The role of routine bronchoscopy for early detection of bronchial stump recurrence of lung cancer-1 year post-surgery

Lung Cancer

Volumn 65, Issue 3, 2009, Pages 319-323

  Peled, Nir ^a,b   Flex, Dov ^a   Raviv, Yael ^a   Fox, Benjamin D ^a   Shitrit, David ^a   Refaeli, Yael ^a   Sauté, Milton ^a   Amital, Anat ^a   Kramer, Mordechai R ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Bronchial stump; Bronchoscopy; Dysplasia; Early detection; Lung cancer; Screening

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FISHER EXACT TEST; HIGH RISK PATIENT; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; POLYP; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SQUAMOUS CELL METAPLASIA;

AGED; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PNEUMONECTOMY; POLYPS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 67651233221     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.12.006     Document Type: Article

References (37)

1. Wind J., Smit E.J., Senan S., and Eerenberg J.P. Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg 32 1 (2007) 29-34
2. Hofmann H.S., Taege C., Lautenschläger C., Neef H., and Silber R.E. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 21 4 (2002) 606-610
3. Ghiribelli C., Voltolini L., Paladini P., Luzzi L., Di Bisceglie M., and Gotti G. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump. Eur J Cardiothorac Surg 16 5 (1999) 555-559
4. Griess D.F., McDonald J.R., and Clagett O.T. The proximal extension of carcinoma of the lung in the bronchial wall. J Thorac Surg 14 (1945) 362-368
5. Hofmann H.S., Taege C., Lautenschlager C., Neef H., and Silber R.E. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg 21 (2002) 606-610
6. Liewald F., Hatz R.A., Dienemann H., and Sunder-Plassmann L. Importance of microscopic residual disease at the bronchial margin after resection for non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 104 (1992) 408-412
7. Snijder R.J., Brutel de la Riviere A., Elbers H.J.J., and van der Bosch J.M.M. Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin. Ann Thorac Surg 65 (1998) 212-216
8. Kimura H., and Yamaguchi Y. Survival of noncuratively resected lung cancer. Lung Cancer 11 (1994) 229-242
9. Harpole Jr. D.H., Herndon II J.E., Young Jr. W.G., Wolfe W.G., and Sabiston Jr. D.C. Stage I no-small cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 76 (1995) 787-796
10. Lafitte J.J., Ribet M.E., Prévost B.M., Gosselin B.H., Copin M.C., and Brichet A.H. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. Ann Thorac Surg 62 (1996) 830-834
11. Trodella L., Granone P., Valente S., Valentini V., Balducci M., Mantini G., et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol 62 (2002) 11-19
12. Van Houtte P., Rocmans P., Smets P., Goffin J.C., Lustman-Maréchal J., Vanderhoeft P., et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6 (1980) 983-986
13. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med 1986;315:1377-1381.
14. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K., et al. A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86 (1999) 265-273
15. Rosell R., Gómez-Codina J., Camps C., Maestre J., Padille J., Cantó A., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
16. Stephens R.J., Girling D.J., Bleehen N.M., Moghissi K., Yosef H.M., and Machin D. The role of postoperative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party. Brit J Cancer 74 (1996) 632-639
17. Feld R., Rubinstein L.V., and Weisenberger T.H. Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol 2 (1984) 1352-1358
18. Kelsey C.R., Clough R.W., and Marks L.B. Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy. Cancer J 12 4 (2006) 283-288
19. Tada T., Fukuda H., Nakagawa K., Matsui K., Hosono M., Takada Y., et al. Non-small cell lung cancer: radiation therapy for locoregional recurrence after complete resection. Int J Clin Oncol 10 (2005) 425-428
20. Kelsey C.R., Clough R.W., and Marks L.B. Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy. Cancer J 12 (2006) 283-288
21. Onishi H., Araki T., Shirato H., Nagata Y., Hiraoka M., Gomi K., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
22. Thomas P., and Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Ann Thorac Surg 49 (1990) 242-247
23. Field R., Rubinstein L., and Weisenberger T. Site of recurrence in resected stage I non-small cell lung cancer. A guide for future studies. Int J Radiat Oncol Biol Phys 2 (1984) 1352-1358
24. Immerman S., Vanecko R., and Fry W. Site of recurrence in patients with stage I and II carcinoma of the lung resected for cure. Ann Thorac Surg 32 (1981) 23-27
25. Ishida T., Yano T., Maeda K., Kaneko S., Tateishi M., and Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 50 (1990) 708-713
26. Jang K.M., Lee K.S., Shim Y.M., Han D., Kim H., Kwon O.J., et al. The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging. J Thorac Imag 18 4 (2003) 225-230
27. Kara M., Sak S.D., Orhan D., and Yavuzer S. Changing patterns of lung cancer; (3/4 in.) 1.9 cm; still a safe length for bronchial resection margin?. Lung Cancer 30 3 (2000) 161-168
28. Frost J.K., Ball Jr. W.C., Levin M.L., Tockman M.S., Erozan Y.S., Gupta P.K., et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med 28 (1986) 692-703
29. Bota S., Auliac J.B., Paris C., Metayer J., Seboue R., Nouvet G., et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 164 (2001) 1688-1693
30. Lam S., Slivinskas J., IeRiche J.C., MacAulay C., McWilliams A., Szabo E., et al. Natural history of premalignant bronchial lesions: implications for chemoprevention. Presented at American Association for Cancer Research Frontiers in Cancer Prevention Research Meeting (2002)
31. Kennedy TC, McWilliams A, Edell E, Sutedja T, Downie G, Yung R, et al. Diagnosis and management of lung cancer: ACCP guidelines (2nd editions): Bronchial Intraepithelial Neoplasia/Early Central Airways Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd edition). Chest, September 2007;132:221S-233S.
32. Melamed M.R. Lung cancer screening results in the National Cancer Institute New York study. Cancer 89 11 Suppl. (2000) 2356-2362
33. Frost J.K., Ball W.C., Levin M.L., Tockman M.S., Baker R.R., Carter D., et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am Rev Respir Dis 130 (1984) 549-554
34. Byers T., Wolf H.J., Franklin W.A., Braudrick S., Merrik D.T., Shroyer K.R., et al. Sputum cytology atypia predicts incident lung cancer: defining latency and histologic specificity. Cancer Epidemiol Biomark Prev 17 1 (2008) 158-162
35. Hirsch F.R., Prindiville S.A., Miller Y.E., Franklin W.A., Dempsey E.C., Murphy J.R., et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 39 18 (2001) 1385-1391
36. Vincent B.D., Fraig M., and Silvestri G.A. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest 131 6 (June) (2007) 1794-1799
37. Lam B, Lam SY, Wong MP, Ooi CGC, Fong DYT, Lam DCL, et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer 2008; Nov 14 [Epub ahead of print].